Evidence map›Paper›PMID 30195949›Full record

Trial reportDrug and alcohol dependence2018

The interplay between externalizing disorders polygenic risk scores and contextual factors on the development of marijuana use disorders.

Jill A Rabinowitz, Rashelle J Musci, Adam J Milam, Kelly Benke, George R Uhl, Danielle Y Sisto, Nicholas S Ialongo, Brion S Maher

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jill A RabinowitzDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD 21205, United States. Electronic address: Jrabino3@jhu.edu.
Rashelle J MusciDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD 21205, United States.
Adam J MilamDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD 21205, United States.
Kelly BenkeDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD 21205, United States.
George R UhlNew Mexico VA Healthcare System, 1501 San Pedro Drive, SE, Albuquerque, NM, 87108 United States.
Danielle Y SistoDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD 21205, United States.
Nicholas S IalongoDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD 21205, United States.
Brion S MaherDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD 21205, United States.
Johns Hopkins University · USNew Mexico VA Health Care System · US

Funding

NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
Development & Malleability from Childhood to AdulthoodR01DA044184 · NIDA · JOHNS HOPKINS UNIVERSITY · PI IALONGO, NICHOLAS S · 2018 to 2022
$3.9M
FOLLOWUP OF TWO UNIVERSAL PREVENTIVE INTERVENTIONSR01DA011796 · NIDA · JOHNS HOPKINS UNIVERSITY · PI IALONGO, NICHOLAS S · 1999 to 2004
$2.0M
Genes, Environment and Drug Use in Three Baltimore CohortsR01DA036525 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MAHER, BRION S · 2015 to 2017
$727k
NIDA NIH HHS R01 DA011796NIDA NIH HHS R01 DA036525NIDA NIH HHS R01 DA044184NIDA NIH HHS T32 DA007292
6 · The paper itself

Abstract

Externalizing disorders have been extensively linked to substance use problems. However, less is known about whether genetic factors underpinning externalizing disorders and environmental features interact to predict substance use disorders (i.e., marijuana abuse and dependence) among urban African Americans. We examined whether polygenic risk scores (PRS) for conduct disorder (CD) and attention-deficit hyperactivity disorder (ADHD) interacted with contextual factors (i.e., parental monitoring, community disadvantage) to influence risk for marijuana use disorders in a sample of African American youth. Participants (N=1,050; 44.2% male) were initially recruited for an elementary school-based universal prevention trial in a Mid-Atlantic city and followed through age 20. Participants reported on their parental monitoring in sixth grade and whether they were diagnosed with marijuana abuse or dependence at age 20. Blood or saliva samples were genotyped using the Affymetrix 6.0 microarrays. The CD and ADHD PRS were created based on genome-wide association studies conducted by Dick et al. (2010) and Demontis et al. (2017), respectively. Community disadvantage was calculated based on census data when participants were in sixth grade. There was an interaction between the CD PRS and community disadvantage such that a higher CD PRS was associated with greater risk for a marijuana use disorder at higher levels of neighborhood disadvantage. This finding should be interpreted with caution owing to the number of significance tests performed. Implications for etiological models and future research directions are presented.

Indexed as

Genome-Wide Association StudyAdolescentAttention Deficit Disorder with HyperactivityChildComorbidityConduct DisorderDisease SusceptibilityFemaleHumansMaleMarijuana AbuseMarijuana UseMultifactorial InheritanceYoung AdultAttention-deficit hyperactivity disorder polygenic risk scoreCommunity disadvantageConduct disorder polygenic risk scoreMarijuana abuse and dependenceParental monitoring

Identifiers

PMID30195949
PMCPMC8005265
OpenAlexW2888619809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.